Navigation Links
Novalung Records 50% Growth
Date:3/23/2010

ANN ARBOR, Mich., March 23 /PRNewswire/ -- The innovative therapies for lung failure from medical device company Novalung GmbH continue to gain acceptance.  Additional financing will allow the Talheim (Germany) based company to accelerate the development of new products.

Novalung GmbH increased sales by 50% in 2009.  The increasing acceptance of the company's innovative therapies for lung failure both in Germany and abroad is driving continuing growth. Manufacturing operations moved into a new, larger clean-room facility at the end of 2009.

In order to maintain this growth and to fund further international expansion, the private equity group Zukunftsfonds Heilbronn GmbH & Co.KG ("Future Fund of Heilbronn", zfhn) and the LBank, state bank of Baden-Wurttemberg, completed an additional financing round for Novalung. The zfhn acted as lead investor for the second time.

Thanks to the additional funding, commercialization of new products can be pursued more aggressively. These measures put Novalung in an excellent position to establish itself internationally as the pioneering provider of solutions for lung failure, and to revolutionize the treatment of lung failure with new therapies.


'/>"/>
SOURCE Novalung, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Praxis Electronic Medical Records Announces New Version 5 With Breakthrough in EHR Documentation
2. Aprima and MednetwoRx Partner to Provide Electronic Health Records and Remote Hosting Option to Physician Practices
3. Vicus Therapeutics Records Last Patient Visit of Phase 2, VT-122 Trial for the Treatment of Cachexia in Patients With Advanced Lung Cancer
4. Kensey Nash To Participate in the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum
5. NOVAVAX to Present at 22nd Annual ROTH OC Growth Stock Conference
6. Vermillion to Present at the Roth 22nd Annual OC Growth Stock Conference March 15 - 17, Laguna Niguel, CA
7. Keryx Biopharmaceuticals to Present at the 22nd Annual ROTH OC Growth Stock Conference
8. Anadys Pharmaceuticals to Present at the ROTH OC Growth Stock Conference
9. International Growth Continues: Rhythmlink International, LLC Receives CE Marking & ISO 13485 Certification
10. DUSA Pharmaceuticals to Present at Roth Capital Partners 22nd Annual OC Growth Stock Conference
11. Acuo Technologies Announces Another Significant Sales and Implementation Growth Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 29, 2014   ViaDerma, Inc. (OTCQB: ... new products to market, is committed to pursuing ... developed an innovative, patent-pending dual carrier transdermal delivery ... pharmaceutical active ingredients to penetrate the skin and ... The transdermal delivery method also overcomes microbial drug ...
(Date:10/30/2014)... , Oct. 30, 2014 Today Eli ... details of its long-standing technology transfer program to increase ... Begun in 2003, the effort included Lilly donating manufacturing ... in China , India ... South Africa – all MDR-TB ,hot ...
(Date:10/27/2014)... CHICAGO , Oct. 27, 2014  Demonstrations ... and devices are being featured this week in ... 2014 Scientific Assembly where more than 7,000 emergency ... medicine and participating in educational courses. ... back drop of true-to-life emergency department environments, including ...
Breaking Medicine Technology:ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 2Lilly Shares Insights from Decade-Long Technology Transfer Experience 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 4Emergency Medicine of the Future Demonstrated at ACEP14 2Emergency Medicine of the Future Demonstrated at ACEP14 3Emergency Medicine of the Future Demonstrated at ACEP14 4Emergency Medicine of the Future Demonstrated at ACEP14 5Emergency Medicine of the Future Demonstrated at ACEP14 6Emergency Medicine of the Future Demonstrated at ACEP14 7Emergency Medicine of the Future Demonstrated at ACEP14 8Emergency Medicine of the Future Demonstrated at ACEP14 9Emergency Medicine of the Future Demonstrated at ACEP14 10Emergency Medicine of the Future Demonstrated at ACEP14 11Emergency Medicine of the Future Demonstrated at ACEP14 12Emergency Medicine of the Future Demonstrated at ACEP14 13Emergency Medicine of the Future Demonstrated at ACEP14 14Emergency Medicine of the Future Demonstrated at ACEP14 15
(Date:10/29/2014)... study has found that certain prostate cancer medications are ... causes in men with congestive heart failure or prior ... findings will help doctors and patients weigh the benefits ... therapy (ADT), which reduces levels of male hormones in ... is a mainstay of treatment for prostate cancer. Despite ...
(Date:10/28/2014)... 27, 2014)—Although oral hormonal therapy is known to ... hormone receptor–positive tumors, about one-half of patients fail ... by Columbia University Medical Center (CUMC) researchers has ... (the most common type of hormone therapy), which ... increased treatment adherence by 50 percent. , The ...
(Date:10/27/2014)... for informal caregiving of elderly people by friends and ... a year, according to a new RAND Corporation study. ... minimum wage would cost $221 billion, while replacing ... annually. , The study, published online by the ... the value of informal caregiving by making use of ...
(Date:10/27/2014)... adopt a new therapy by watching others use it, ... , New technology is like an influential colleague -- ... reminded every five to seven days , CHICAGO ... when they are persuaded to do so by an influential ... adopting innovations also have relevance for business, education and research. ...
(Date:10/27/2014)... (PRWEB) October 27, 2014 CALNOC, ... announced its annual CALNOC Performance Excellence Awards recognizing ... of reducing hospital acquired pressure ulcers, injuries from ... their commitment and dedication to nursing quality. , ... and affiliation. These hospitals have a long and ...
Breaking Medicine News(10 mins):Health News:Prostate cancer medications linked with increased risk of heart-related deaths in men with cardiovascular problems 2Health News:Generic medications boost adherence to breast cancer therapy 2Health News:Generic medications boost adherence to breast cancer therapy 3Health News:Cost of informal caregiving for US elderly is $522 billion annually, study finds 2Health News:Persuading doctors to quickly adopt new treatments 2Health News:Persuading doctors to quickly adopt new treatments 3Health News:CALNOC Presents Performance Excellence Awards to Hospitals at Annual Conference in San Diego 2Health News:CALNOC Presents Performance Excellence Awards to Hospitals at Annual Conference in San Diego 3Health News:CALNOC Presents Performance Excellence Awards to Hospitals at Annual Conference in San Diego 4
... Texas, Dec. 17 ULURU Inc. (Amex:,ULU) today ... Allowance from the,United States Patent and Trademark Office ... the underlying science behind the Company,s,nanoparticle aggregate technology; ... patent portfolio., Commenting on the issuance of ...
... 17 CSG/SportsCoatings,today announced a major deal ... and FabricAide(TM), to 25 high schools in,Virginia,s ... School District is the model for how ... steps towards minimizing prevalent,bacterial issues like staph ...
... acute and recurrent chronic pain are the leading causes of ... low as 2 percent when these soldiers are treated outside ... percent when troops and officers are treated and managed for ... for therapy, according to a new study from a Johns ...
... Researchers at Oregon Health & Science University have ... a study that suggests new strategies may be in ... The research is published in the current edition of ... The research focused on an important component of the ...
... cardiac safety, TAMPA, Fla., Dec. 17 ... in electro-stun technology, today,announced a major research university ... Systems, S-200 projectile stun gun. Details of the,study ... meeting and/or,in a scientific journal. However, this study ...
... Available Today, Offers Great ... and Now Even More Heart Benefits, HORSHAM, ... -- and then bulge -- from holiday parties ... availability of,NutriSystem Advanced, the company,s breakthrough weight-loss, health ...
Cached Medicine News:Health News:ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent 2Health News:Virginia School District Gets Proactive Against MRSA 2Health News:Pain treatment in the field: Good for soldiers' comfort and better for rebuilding troop strength 2Health News:OHSU research suggests new strategy for protecting aging Americans against infectious disease 2Health News:Medical Study of Stinger S-200 Stun Gun Completed 2Health News:With Calorie Counting on Holiday Hiatus, NutriSystem Offers 'Advanced' Resolution for 2008 2Health News:With Calorie Counting on Holiday Hiatus, NutriSystem Offers 'Advanced' Resolution for 2008 3Health News:With Calorie Counting on Holiday Hiatus, NutriSystem Offers 'Advanced' Resolution for 2008 4
... powerful, lightweight, easy to ... durable foam silicone rubber ... by machine washable cotton ... easily adjusts to all ...
Xenon surgical headlight system is durable, comfortable, lightweight and deliver dependable bright light through a patented shielded fiber optic bundle. It is easy to wear....
View Mex-3 is designed for out-patient surgery, hospital rounds and house calls....
Headlight module is mounted on UltraLite Plus sweatband....
Medicine Products: